GBI Research, Feb 2010, Pages: 85
Strategies
6 The Pharmaceutical Pipeline and LCM Today – Cancer and CNS on the Top
6.1 The Pharmaceutical Pipeline and the Lifecycle Management Landscape
6.2 Analysis of the Top Five Lifecycle Management
Business Insights, Oct 2005
'The CNS Market Outlook to 2010' provides detailed analysis on 7 key indications in the CNS Market, identifying growth brands, leading companies and epidemiology and product sales forecasts over the period
GBI Research, Nov 2010, Pages: 85
for the Oral Drug Delivery Market.
- Analysis of competitivelandscape and the leading market players.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Formulate
Decision Resources, Inc., April 2010, Pages: 35
Strategic Considerations
Stakeholder Implications
Looking for Opportunities
Forecast Market Growth, 2008 to 2015
Major Brands in Neurology Markets
Near-Term Competition from Drugs in Late-Stage
Biophoenix Limited, Feb 2009, Pages: 312
modulators in cancer, CNS diseases, and chronic inflammation/autoimmunity. - Gain up-to-date competitive intelligence on apoptosis-modulating pipelines and identify the most promising drugs under development
Business Insights, Sep 2008, Pages: 253
across major RNAi market segments. Identify the developmental status of key RNAi agents, review the latest advances in RNAi technologies and assess the competitivelandscape with this report’s analysis
Markets and Markets, Nov 2010, Pages: 311
and opportunities, top-selling products, key players, and competitiveoutlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides more
Global Industry Analysts, Inc., Aug 2011, Pages: 1305
as the fastest growing market with a CAGR of 28% over the analysis period. A key factor fueling market growth in Asia is the ever-growing information technology industry in the region. The biomarker technologies
